A Study of Subcutaneous Lecanemab in Healthy Participants

NCT05045716 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Lecanemab
DRUG: Lecanemab

Sponsor

Eisai Inc.